Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: Pancreas. 2018 Aug;47(7):856–863. doi: 10.1097/MPA.0000000000001090

FIGURE 3.

FIGURE 3

Anti-NGF does not alter the development of primary pancreatic disease. A, Hemotoxylin and eosin staining of sections of pancreas from low- and high-grade PanIN lesions and PDAC tumor. Fibro-inflammatory stroma is demarcated between dotted and straight lines. B, The distribution of diagnoses was similar across treatment groups when compared using a cumulative link model. C–F, Charts indicate the percent area occupied by lesion, fibro-inflammatory stroma and PDAC tumor in pancreata of KPC mice. No significant difference in area is found in comparison of all groups using a two-way ANOVA. n = 10–12/group.